|By Marketwired .||
|December 24, 2013 11:24 AM EST||
SAGINAW, MI -- (Marketwired) -- 12/24/13 -- HPIL Holding (the "Company" or "HPIL") (OTCQB: HPIL) is pleased to announce that its wholly owned subsidiary HPIL HEALTHCARE Inc., on December 20, 2013, entered into a Cooperation Agreement (the "Agreement") with MB INGENIA SRL ("MB"), a private company focused on investing in the healthcare sector. The parties will work cooperatively to develop and expand projects between the parties beginning on December 20, 2013. The term of the Agreement is two (2) years unless terminated earlier by either party.
Louis Bertoli, President & CEO of HPIL Holding, said, "We look forward to working with MB through HPIL Holding's wholly owned subsidiary HPIL HEALTHCARE Inc. The business of healthcare is of our main interest and we expect productive cooperation between MB and HPIL HEALTHCARE Inc."
Mr. Michael Bertoli, President & CEO of MB, said, "We are pleased with our agreement with HPIL HEALTHCARE Inc. and we anticipate a significant cooperative relationship with HPIL HEALTHCARE Inc. in 2014 and beyond."
For more information about MB, please visit www.mbingenia.it.
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (The "Act"). In particular, when used in the preceding discussion, the words "pleased," "plan," "confident that," "believe," "expect," "anticipate," or "intend to," and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. Such risks and uncertainties include, but are not limited to, market conditions, general acceptance of the Company's products and technologies, competitive factors, the ability to successfully complete additional financings and other risks described in the Company's SEC reports and filings.
For more information, please contact: